Latest Bioequivalence Stories

2014-08-05 23:03:14

OMICS Group International schedules its 5th World Congress on Bioavailability and Bioequivalence: Pharmaceutical R&D Summit during September 29 to October 01, 2014 at Baltimore, USA with an aim to Revolutionize the Next Generation Medicines using innovative Bioavailability and Bioequivalence (BA/BE) approaches and Studies. Los Angeles, CA (PRWEB) August 05, 2014 Speaking for this occasion, CEO of the OMICS Group International, Dr. Srinubabu Gedela observed that several high profile...

2014-06-24 23:14:41

There are several common mistakes in ANDA submissions that can be avoided to ensure speedy approval. Learn what those mistakes are and what to do about them on July 15 at the FDAnews webinar led by 30-year industry expert Dr. Andy Papas, Vice President of Regulatory Affairs at NSF Health Sciences Pharma Biotech. Falls Church, VA (PRWEB) June 24, 2014 Expedite Your FDA Generic Drug Approval: Deliver Flawless ANDAs the First Time **FDAnews Webinar** July 15, 2014 — 1:30 p.m. – 3:00...

2014-06-19 23:14:27

Fully Integrated CRO Avomeen Invites Pharmaceutical Developers to Connect at BIO 2014 (Booth #1259) San Diego, CA (PRWEB) June 19, 2014 Avomeen Analytical Services will be joining thousands of pharmaceutical companies, researchers, academics, and biotech companies in San Diego for the BIO 2014 International Convention. Their contract services for pharmaceutical development, medical device testing, extractables/leachables, CTM, and more will be highlighted at booth #1259. Knowledgeable...

2014-05-19 08:29:19

Scilex has commenced with its pivotal bioequivalence study of Ztilido versus Lidoderm® in accordance with FDA recommendations to support approval of Ztilido submitted as a 505(b)(2) NDA MALVERN, Pa., May 19, 2014 /PRNewswire/ -- SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of late-stage pharmaceutical products focused on the treatment of pain, announced today that it has initiated a pivotal pharmacokinetic (PK) study of its investigational...

2014-04-18 23:08:24

OMICS Group announces the 5th World Congress on Bioavailabity and Bioequivalence: Pharmaceutical R&D Summit during Sep 29 - Oct 01, 2014 at Baltimore, USA with the theme “Innovative Approaches of BABE to Revolutionize the Next Generation Medicine” Los Angeles, CA (PRWEB) April 18, 2014 BABE-2014 is all set to explore the innovations, advancements in the field of pharmaceutical industry, which shows significant impact on the development of new and improved generic drugs. These...

2014-03-17 12:27:07

"Nature-Equivalent" Material Will Offer Improved Quality and Bioavailability to Consumers and Help Industry Meet Burgeoning Demand ORLANDO, Fla., March 17, 2014 /PRNewswire/ -- Valensa International announced today that it will begin to offer ZanthinNEX(®) Astaxanthin commercially in late 2014. ZanthinNEX is a form of the carotenoid Astaxanthin produced via a proprietary process using natural enzymatic conversions that delivers a safe finished product that is 'nature equivalent' to...

Word of the Day
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.